期刊文献+

慢性阻塞性肺疾病合并肺血栓栓塞症的临床特征分析 被引量:1

Retrospective analysis of clinical features of chronic obstructive pulmonary disease complicated with pulmonary thromboembolism
原文传递
导出
摘要 目的分析慢性阻塞性肺疾病(COPD)合并肺血栓栓塞症(PTE)患者的临床特征.方法回顾性分析太原市中心医院2015年6月至2018年3月收治的COPD合并PTE患者21例与COPD急性加重期(AECOPD)患者26例的临床资料,采用SPSS 22.0统计软件对两组的一般资料、血气分析结果、肺功能、血红蛋白、凝血指标、合并疾病进行分析.结果 COPD合并PTE组与AECOPD组年龄、性别、肺功能分级差异均无统计学意义(均P>0.05).COPD合并PTE组胸痛(8例,38.1%)、晕厥(2例,10.5%)发生比例均高于AECOPD组[胸痛(3例,11.5%)、晕厥(1例,3.8%)](x2=7.645、9.413,均P<0.05).两组二氧化碳分压(PaCO2)差异无统计学意义(P>0.05);COPD合并PTE组血氧分压(PaO2)为(62.86±15.10) mmHg,低于AECOPD组的(74.83±17.59) mmHg(t=4.642,P<0.05);COPD合并PT组血红蛋白、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、D-二聚体分别为(146.78±21.40) g/L、(35.62±5.93)s、(4.34±1.18) g/L、(5.02±3.63) mg/L,均高于AECOPD组的(137.45±15.15) g/L、(29.38±3.16)s、(3.62±1.08)g/L、(0.92±0.42) mg/L(t=4.375、4.654、3.869、18.653,均P<0.05).两组糖尿病、高血压、高脂血症、下肢血静脉曲张等合并症比例差异均无统计学意义(均P >0.05).结论 COPD合并PTE患者有以下特点:高龄,男性患者占比高,胸痛、晕厥症状发生比例高,缺氧程度较重,血红蛋白、D-二聚体明显增高. Objective To analyze the clinical features of patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary thromboembolism ( PTE). Methods The clinical data of 21 patients with COPD and PTE and 26 patients with acute exacerbation of COPD ( AECOPD) from June 2015 to March 2018 in Taiyuan Central Hospital were retrospectively analyzed. The SSPS 22. 0 statistical software was used to analyze the clinical data. General data, blood gas analysis results, lung function, hemoglobin, coagulation parameters, combined disease were analyzed. Results There were no statistically significant differences in age, gender and lung function grading between the COPD complicated with PTE group and AECOPD group ( all P > 0. 05 ). The incidence rates of chest pain(8 cases,38. 1%) and syncope(2 cases, 10. 5%) in the COPD complicated with PTE group were higher than those in the AECOPD group [ chest pain (3 cases ,11. 5%), syncope(1 case,3. 8%)](X2 = 7. 645,9. 413 , all P < 0. 05). There was no statistically significant difference in carbon dioxide partial pressure ( PaCO2 ) retention between the two groups(P > 0. 05 ). The blood oxygen partial pressure ( PaO2 ) of the COPD complicated with PTE group was (62. 86 ± 15. 10) mmHg,which was lower than that of the AECOPD group [(74. 83 ± 17. 59) mmHg](i = 4. 642,P<0. 05 ). The hemoglobin,activated partial thromboplastin time( APTT), fibrinogen ( FIB), D - dimer levels in the COPD complicated with PTE group were ( 146. 78 ± 21.40) g/L,( 35. 62 ± 5. 93) s,(4. 34 ± 1. 18 ) g/L,(5. 02 ± 3. 63 ) mg/L, respectively, which were higher than those in the AECOPD group [( 137. 45 ± 15. 15 ) g/L,(29. 38 ±3.16)s,(3.62±1.08)g/L,(0.92 ±0.42)mg/L](t =4. 375,4.654,3. 869,18.653,all P <0.05). There were no statistically significant differences in the proportion of comorbidities such as diabetes, hypertension, hyperlipidemia and lower extremity ( all P > 0. 05 ). Conclusion COPD patients complicated with PTE have the following characteristics: elderly and male patients accounted for a high proportion, chest pain and syncope symptoms occurred in a high proportion, severe hypoxia, hemoglobin and D - dimer increased significantly.
作者 武晓兰 王萍 郭长城 春睿君 刘瑞平 Wu Xiaolan;Wang Ping;Guo Changcheng;Chun Ruijun;Liu Ruiping(Department of Respiratory and Critical Care Medicine, Taiyuan Central Hospital, Taiyuan, Shanxi 030000, China)
出处 《中国基层医药》 CAS 2019年第17期2049-2052,共4页 Chinese Journal of Primary Medicine and Pharmacy
基金 国家重点研发计划项目(2016YFC0905600).
关键词 肺疾病 慢性阻塞性 栓塞和血栓形成 肺栓塞 血气分析 呼吸功能试验 疾病特征 Pulmonary disease chronic obstructive Embolism and thrombosis Pulmonary embolism Blood gas analysis Respiratory function tests Disease attributes
  • 相关文献

参考文献8

二级参考文献74

  • 1国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:78
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1789
  • 3Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001,119 : S132-175.
  • 4Moser KM, LeMoine JR, Nachtwey FJ, et al. Deep venous thrombosis and pulmonary embolism: frequency in a respiratory. intensive care unit. JAMA, 1981,246 : 1422-1424.
  • 5Cade JF. High risk of the critically ill for thromboembolism. Crit Care Med, 1982,10 : 448-450.
  • 6Goldberg SK, Lippmann ML, Walkenstein MD, et al. The prevalence of DVT among patients in respiratory failure: the role of DVT prophylaxis [abstract]. Am J Respir Crit Care Med, 1996,153 : A94.
  • 7Kapoor M, Kupfer YY, Tessler S. Subcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill [ abstract ]. Crit Care Med, 1999,27 Suppl : $69.
  • 8Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med,2000,161 : 1109-1114.
  • 9Sehonhofer B, Kohler D. Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease. Respiration, 1998,65(3) : 173-177.
  • 10Harris LM, Curl GR, Booth FV, et al. Screening for asyptomatie deep vein thrombosis in surgical intensive care patients. J Vasc Surg, 1997,26:764-769.

共引文献1139

同被引文献20

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部